Bicalutamide is used for the treatment of advanced prostate carcinoma. It is taken together with a drug known as a luteinising
hormone-releasing hormone (LHRH) analogue which reduces the levels of androgens (male sex hormones) within the body, or with accompanying surgical removal of the testicles. Bicalutamide is one of a group of medicines known as the non-steroidal antiandrogens. The active substance bicalutamide blocks the undesired effect of the male sex hormones (androgens) and inhibits cell growth in the prostate in this way.